ZyVersa Therapeutics, Inc. (ZVSA)

ZyVersa Therapeutics Statistics

Total Valuation

ZVSA has a market cap or net worth of $1.21 million. The enterprise value is $1.09 million.

Market Cap	1.21M
Enterprise Value	1.09M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

ZVSA has 1.07 million shares outstanding. The number of shares has decreased by -97.10% in one year.

Current Share Class	1.07M
Shares Outstanding	1.07M
Shares Change (YoY)	-97.10%
Shares Change (QoQ)	+18.38%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	7.95%
Float	1.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.17
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio	0.03
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-72.74

Financial Efficiency

Return on equity (ROE) is -159.59% and return on invested capital (ROIC) is -44.96%.

Return on Equity (ROE)	-159.59%
Return on Assets (ROA)	-23.02%
Return on Capital (ROIC)	-44.96%
Revenue Per Employee	n/a
Profits Per Employee	-$4.18M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-586,361
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.77% in the last 52 weeks. The beta is 0.64, so ZVSA's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-95.77%
50-Day Moving Average	1.98
200-Day Moving Average	4.44
Relative Strength Index (RSI)	32.04
Average Volume (20 Days)	3,578,859

Short Selling Information

The latest short interest is 45,485, so 4.23% of the outstanding shares have been sold short.

Short Interest	45,485
Short Previous Month	9,687
Short % of Shares Out	4.23%
Short % of Float	4.26%
Short Ratio (days to cover)	0.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.63M
Pretax Income	-22.42M
Net Income	-29.28M
EBITDA	-9.62M
EBIT	-9.63M
Earnings Per Share (EPS)	-$43.97

Balance Sheet

Cash & Cash Equivalents	122,921
Total Debt	n/a
Net Cash	122,921
Net Cash Per Share	$0.11
Equity (Book Value)	7.03M
Book Value Per Share	6.54
Working Capital	-11.15M

Cash Flow

Operating Cash Flow	-9.12M
Capital Expenditures	n/a
Free Cash Flow	-9.12M
FCF Per Share	-$8.49

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ZVSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	97.10%
Shareholder Yield	97.10%
Earnings Yield	-2,412.05%
FCF Yield	-751.53%

Analyst Forecast

The average price target for ZVSA is $240.00, which is 21,138.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$240.00
Price Target Difference	21,138.94%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-44.38%

Stock Splits

The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Apr 26, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1